참고문헌
- Kaye EM, vander Knaop MS. Disorders primarily of white matter. In: Swaiman KF, editor. Pediatric Neurology: principles & practice. 4th ed. Volume 2, Philadelphia: Mosby, 2006:1346-72
- Godoth N. Multiple sclerosis in children. Brain Dev 2003;25:229-32 https://doi.org/10.1016/S0387-7604(03)00035-4
- Ozakbas S, Idiman E, Baklan B, Yulug B. Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features. Brain Dev 2003;25:233-6 https://doi.org/10.1016/S0387-7604(03)00034-2
- Hillert J, Olerup O. Multiple sclerosis is associated with genes within or close to the HLA DR-DQ subregion on a normal DR115, DQ6, DW2 haplotype. Neurology 1993;43: 163-8 https://doi.org/10.1212/WNL.43.1_Part_1.163
- Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Age depedence of clinical and pathological manifestation of autoimmune demylination. Implications for multiple sclerosis. Am J Pathol 1999;155:1147-61 https://doi.org/10.1016/S0002-9440(10)65218-2
- Lampert PW. Autoimmune and virus induced demyelinating disease. Am J Pathol 1978;91:176-97
- Rose AS, Ellison GW, Meyers LW, Tourtellotte WW. Criteria for clinical diagnosis of multiple sclerosis. Neurology 1976;26:20-2 https://doi.org/10.1212/WNL.26.6_Part_2.20
- Poser CM, Party DW, Scheinberg L, Mcdonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis; guidelines for research protocols. Ann Neurol 1983;13:227-31 https://doi.org/10.1002/ana.410130302
- McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the Hnternational Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50: 121-7 https://doi.org/10.1002/ana.1032
- Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni F, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol 2005;62:865-70 https://doi.org/10.1001/archneur.62.6.865
- Kesslring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D, et al. Acute disseminated encephalomyelitis; MRI findings and distinction from multiple sclerosis. Brain 1990;113:291-302 https://doi.org/10.1093/brain/113.2.291
- Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22 https://doi.org/10.1093/brain/123.12.2407
- Kupersmith MJ, Kaufmann D, Paty DW, Ebers G, Mcfarland H, Johnson K, et al. Megadose corticosteroids in multiple sclerosis. Neurology 1994;44:1-4 https://doi.org/10.1212/WNL.44.1.1
- Barnes MP, Bateman DE, Cleland PG, Dick DJ, Walls TJ, Newman PK, et al. Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry 1985;48:157-9 https://doi.org/10.1136/jnnp.48.2.157
- Adams AB, Tyor WR, Holden KR. Interferon beta-1b and childhood multiple sclerosis. Pediatr Neurol 1999;21:481-3 https://doi.org/10.1016/S0887-8994(99)00007-7
-
Ross C, Clemmesen KM, Svenson M, Sorensen PS, Koch-Henriksen N, Skovgaard GL, et al. Immunogenicity of interferon-
$\beta$ in multiple sclerosis patients: influence of preparation,dosage, dose frequency and route of administration. Ann Neurol 2000;48:706-12 https://doi.org/10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.0.CO;2-V -
Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, et al. Interferon-
$\beta$ treatment in paitents with childhood-onset multiple sclerosis. J Pediatr 2001;139:443-6 https://doi.org/10.1067/mpd.2001.117004